Picture of Lytix Biopharma AS logo

LYTIX Lytix Biopharma AS News Story

0.000.00%
no flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Brief: Lytix Biopharma's Partner Verrica Announces Pricing Of Underwritten Public Offering

Nov 22 (Reuters) - Lytix Biopharma AS  LYTIX.OL :
    * SAID ON THURSDAY LICENSING PARTNER VERRICA PHARMACEUTICALS
ANNOUNCES THE PRICING OF A UNDERWRITTEN PUBLIC OFFERING, RAISING
APPROXIMATELY USD 42 MILLION UPON COMPLETION

Source text:  ID:nObiDj3hqa 
Further company coverage:  LYTIX.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Lytix Biopharma AS

See all news